Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Stock-based Compensation (Details Textual) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	0
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount	$ 0
Stock Issued During Period, Value, Employee Benefit Plan	$ 237
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	50.00%
Common Stock Contribution	$ 29	$ 93
Additional Paid-in Capital [Member]
Stock Issued During Period, Shares, Employee Benefit Plan (in shares)	163		0
Stock Issued During Period, Value, Employee Benefit Plan	$ 237
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount	$ 1,007
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	1 year 3 months 18 days